(Press-News.org) Outpatient antibiotic prescribing fell by almost 4% a year between 2011 and 2018, according to a study of prescribing patterns in the largest integrated health care system in the USA, being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) held online this year.
Veterans Affairs (VA) facilities play a large role in the provision of outpatient care across the USA, providing care to over 9 million Veterans at more than 1,200 outpatient clinics.
The researchers speculate that the downward trend may be related to the antibiotic stewardship programmes widely implemented across the Veterans Health Administration (VHA) health-system since 2014.
"We have seen positive steps taken to reduce antibiotic use in VA outpatient clinics, community-based outpatient clinics, emergency departments, and other outpatient settings, and healthcare teams should be congratulated for their ongoing work to reduce unnecessary antibiotic use", says lead author Dr Haley Appaneal from Providence VA Medical Center, Rhode Island, USA.
"But over 8 years, prescriptions for three of the most commonly prescribed outpatient antibiotics--have changed little. And even with that drop in overall prescriptions, the threat of antibiotic resistance is increasing, so there is much more to be done."
In the USA, more than 2.8 million antibiotic-resistant infections occur every year, causing at least 35,000 deaths and $20 billion in health-care costs [1]. According to WHO, infections such as pneumonia, tuberculosis, sepsis, gonorrhoea, and foodborne diseases, are becoming harder, and sometimes impossible, to treat as antibiotics become less effective [2].
Bacteria have long been thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing. Each year, 266 million courses of antibiotics are dispensed to outpatients in the USA [3].
In 2011, the VHA established the National Antimicrobial Stewardship Task Force (ASTF) to help guide implementation and development of antibiotic stewardship programmes in the VA and in 2014, the VHA required all of its hospitals to introduce antibiotic stewardship programmes. Between 2008 and 2015, inpatient antibiotic use decreased substantially by 12% [4].
However, 80-90% of antibiotic use occurs in the outpatient setting, and the US Centers for Disease Control and Prevention (CDC) estimates that at least 30% of outpatient antibiotics are unnecessary (no antibiotic was needed), and up to 50% inappropriate prescribing (unnecessary use and inappropriate selection, dosing and duration) [5].
To provide more evidence on prescribing patterns, researchers analysed data from VA pharmacy datasets to examine trends in antibiotic prescriptions dispensed in VA outpatient clinics across the USA between 2011-2018.
They calculated annual number of days of therapy (DOT) per 100 outpatient visits for all antibiotics and then individually for the 5 most common antibiotics (doxycycline, azithromycin, amoxicillin/clavulanate, ciprofloxacin, and sulfamethoxazole/trimethoprim).
Over 8 years, total antibiotic prescriptions dispensed in the community went down by an average of 3.9% a year, falling from 39.6 DOT/100 visits in 2011 to 29.4 DOT/100 visits in 2018.
The largest decline was in the use of the broad-spectrum antibiotic ciprofloxacin, which decreased by an estimated 12.6% on average per year. The authors point out that here has been a national movement away from the use of fluroquinolones, such as ciprofloxacin, if alternative agents are available due to the harms associated with their use, including Clostridium difficile infection, adverse drug events, and selection of resistance. The VA and the Food and Drug Administration both have issued safety warnings related to fluroquinolones and recommend restricting their use for uncomplicated infections which generally have other safer treatment options, such as acute sinusitis, acute bronchitis, and uncomplicated urinary tract infections (UTI).
The use of sulfamethoxazole/trimethoprim (commonly used for UTIs) also decreased substantially (by around 7% a year).
However, outpatient prescriptions remained unchanged and were high for doxycycline (commonly used to treat skin infections and sexually transmitted infections), azithromycin (widely used for chest, nose, and throat infections), and amoxicillin/clavulanate (used for wide range infections, particularly respiratory) between 2011 and 2018.
"Use of these three commonly prescribed antibiotics remain high and may be an appropriate target for antibiotic stewardship programmes in the VA to further reduce inappropriate outpatient prescribing", says Dr Appaneal. "It might also help combat resistance if national guidelines took stewardship principles into account when making disease-specific recommendations for antibiotic use."
She continues, "Antibiotics are essential for treating serious bacterial infections, such as sepsis, pneumonia and meningitis. But they should not be used to treat acute respiratory conditions such as asthma, coughs, earache and sore throats, which do not respond to these drugs. Antibiotic resistance is not just a matter for clinicians--the public also have a crucial role to play in helping to preserve these vital medicines."
The authors point out several limitations of their study including that it does not take into account prescriptions filled outside the VA system (such as community pharmacies) and may not be complete in all outpatient settings such as the emergency department or outpatient surgery settings. They also note that the study was based on a largely older white male population so the generalisability of the findings to the general US population is limited.
INFORMATION:
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) taking place online (9-12 July), suggests that three commonly prescribed classes of drugs that are not themselves antibiotics--proton pump inhibitors (PPIs), beta-blockers and antimetabolites--could lead to antibiotic resistant infections caused by bacteria from the Enterobacteriaceae family. These antibiotic resistant infections are in turn linked to longer hospital stays and potentially greater risk of death.
The observational study underscores the importance of commonly used non-antimicrobial drugs (NAMDs) as a risk factor for antibiotic resistance, researchers say.
Bacteria are thought to develop antibiotic resistance largely due to repeated exposure through over-prescribing, ...
*Note: this paper is being presented at the European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and is being published in The Lancet Public Health. Please credit both the congress and the journal in your stories*
New research from Switzerland presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, shows that people living in poorer neighbourhoods were less likely to be tested for COVID-19 but more likely to test positive, be hospitalised, or die, compared with those in more wealthy areas. The study is by Professor ...
A new study (the ATOMIC2 trial), presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) and published simultaneously in The Lancet Respiratory Medicine, shows the antimicrobial drug azithromycin - already approved for use in multiple infections - does not prevent mild COVID-19 cases progressing to hospitalisation or death.
The study, by Dr Timothy Hinks, John Radcliffe Hospital and University of Oxford, UK, and colleagues, shows that azithromycin should not be used as a treatment for COVID-19 and all countries must stop using it for this purpose, to prevent resistance developing to azithromycin in other infections.
The SARS-CoV-2 pandemic has not only started a rush to develop new treatments, but also investigations ...
For interviews with the report authors, please contact Dr Waasila Jassat, National Institute for Communicable Diseases of the National Health Laboratory Service, South Africa E) waasilaj@nicd.ac.za T) +27(0)82 927 4138
Alternative contact in the ECCMID Press Room: Tony Kirby T) + 44(0)7834 385827 E) tony@tonykirby.com or Rachael Davies T) +44(0)797 456 0784 E) rachaelvdavies@hotmail.co.uk
Notes to editors:
[1] Wave 1: (14721 deaths/59617625 SA population)*100,000 = 24.7 deaths per 100,000 people
Wave 2: (28682 deaths/59617625 SA population)*100,000 = 48.1 deaths per 100,000 ...
New research presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) shows the importance of receiving the second dose of a COVID-19 vaccine and also the need to constantly review and update vaccines to deal with new variants of concern. The study is by Dr Nicole Schneiderhan-Marra, Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany, and colleagues.
While vaccines have begun to bring the pandemic under control in certain countries, it remains unclear how effective these vaccines will continue to be as the virus mutates and evolves. The protection generated against the virus by vaccination is normally measured by antibodies, with a certain group ...
A presentation at this year's European Congress on Clinical Microbiology & Infectious Diseases (ECCMID), held online this year, will discuss the growing evidence that the beta SARS-CoV-2 variant first identified in South Africa is leading to more severe disease in people living with HIV, and that failure to clear SARS-CoV-2 infection in a patient with advanced HIV creates conditions that can lead to evolution of dangerous mutations in SARS-CoV-2.
Control of HIV with antiretroviral therapy could be the key to preventing such evolution of SARS-CoV-2 in patients with advanced HIV, since clearance of the virus is compromised if HIV is allowed to replicate for ...
Nashville, Tenn. (4:14 p.m. EDT--July 9, 2021)--Orthopedic surgeons know that knee surgeries that require revisions have inferior outcomes compared with primary surgeries but until now, the reason for this was unknown. Today a team of orthopedic physicians reports that opting for a transtibial surgical approach and choosing an inference screw for femoral and tibial fixation will improve the patient's odds of having a significantly better six-year clinical outcome.
The research was presented today at the American Orthopedic Society of Sports Medicine- Arthroscopy Association of North America Combined 2021 Annual Meeting by Rick Wright MD, ...
Sea otters are the smallest marine mammal. As cold-water dwellers, staying warm is a top priority, but their dense fur only goes so far. We have long known that high metabolism generates the heat they need to survive, but we didn't know how they were producing the heat -- until now.
Researchers recently discovered that sea otters' muscles use enough energy through leak respiration, energy not used to perform tasks, that it accounts for their high metabolic rate. The finding explains how sea otters survive in cold water.
Physiologist Tray Wright, research assistant professor in Texas A&M University's College of Education & Human Development, conducted the study along with colleagues ...
In the United States, nearly every pediatric doctor's visit begins with three measurements: weight, height and head circumference. Compared to average growth charts of children across the country, established in the 1970s, a child's numbers can confirm typical development or provide a diagnostic baseline to assess deviations from the curve. Yet, the brain, of vital importance to the child's development, is merely hinted at in these measurements.
Head circumference may indicate a head growth issue, which could be further investigated to determine if there is an issue with brain size or extra fluid. But now, in the age of ...
Growth impairment, a common complication of Crohn's disease in children, occurs more often in males than females, but the reasons are unclear. Now, a physician-scientist from Weill Cornell Medicine and NewYork-Presbyterian and colleagues at eight other centers have found that factors associated with statural growth differ by sex. Their recent publication, identified as the "Editor's Choice / Leading Off" article and receiving a mention on the cover of the June issue of Inflammatory Bowel Diseases, underscores the need for investigating and developing sex-specific treatment strategies for children with Crohn's disease, an approach that is not currently part ...